Test Research Balance Sheet Health
Financial Health criteria checks 6/6
Test Research has a total shareholder equity of NT$7.2B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$8.9B and NT$1.7B respectively. Test Research's EBIT is NT$1.2B making its interest coverage ratio -104.8. It has cash and short-term investments of NT$1.4B.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -104.8x |
Cash | NT$1.35b |
Equity | NT$7.19b |
Total liabilities | NT$1.72b |
Total assets | NT$8.91b |
Recent financial health updates
No updates
Recent updates
Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up
Apr 15Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?
Mar 19With EPS Growth And More, Test Research (TPE:3030) Is Interesting
Mar 01Should You Invest In Test Research (TPE:3030)?
Feb 11Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment
Jan 24Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 05Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?
Dec 18Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock
Nov 30Financial Position Analysis
Short Term Liabilities: 3030's short term assets (NT$5.0B) exceed its short term liabilities (NT$1.4B).
Long Term Liabilities: 3030's short term assets (NT$5.0B) exceed its long term liabilities (NT$272.7M).
Debt to Equity History and Analysis
Debt Level: 3030 is debt free.
Reducing Debt: 3030 has not had any debt for past 5 years.
Debt Coverage: 3030 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3030 has no debt, therefore coverage of interest payments is not a concern.